FDA Steps Up Support For Advanced Manufacturing Technologies The latest article by FDA Commissioner Hahn 1 is one of a string of communications and guidances emphasizing the agency’s support for the adoption of advanced manufacturing technologies (AMTs) and processes. The FDA has defined advanced manufacturing as new and emerging approaches for the production of medical technologies that can improve drug quality, address shortages of medicines, and speed time-to-market. The agency recognizes that AMT subsumes a broad swath of production techniques, including: The integration of novel technology approaches; The use of established techniques in a new or innovative way; Applying production methods in a new domain where there are no defined best practices or experiences.